Oral Biomedicine ›› 2020, Vol. 11 ›› Issue (4): 207-213.
Received:2020-11-11
Revised:2020-12-02
Online:2020-12-25
Published:2021-01-13
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
| [1] | Urist MR.Bone: formation by autoinduction[J].Science, 1965, 150(3698):893-899 |
| [2] | Urist MR, Strates BS.Bone morphogenetic protein[J].J Dent Res, 1971, 50(6):1392-1406 |
| [3] | Kessler E, Takahara K, Biniaminov L, et al.Bone morphogenetic protein-1: the type I procollagen C-proteinase[J].Science, 1996, 271(5247):360-362 |
| [4] | El Bialy I, Jiskoot W, Reza Nejadnik M.Formulation,delivery and stability of bone morphogenetic proteins for effective bone regeneration[J].Pharm Res, 2017, 34(6):1152-1170 |
| [5] | Viljanen VV, Gao TJ, Marttinen A, et al.Partial purification and characterization of bone morphogenetic protein from bone matrix of the premature moose (Alces alces): Degradation of bone-inducing activity during storage[J].Eur Surg Res, 1996, 28(6):447-460 |
| [6] | Wozney J, Rosen V, Celeste A, et al.Novel regulators of bone formation: Molecular clones and activities[J].Science, 1988, 242(4885):1528-1534 |
| [7] | Burkus JK, Transfeldt EE, Kitchel SH, et al.Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2[J].Spine, 2002, 27(21):2396-2408 |
| [8] | Burkus JK, Gornet MF, Dickman CA, et al.Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages[J].J Spinal Disord Tech, 2002, 15(5):337-349 |
| [9] | James AW, LaChaud G, Shen J, et al.A review of the clinical side effects of bone morphogenetic protein-2[J].Tissue Eng Part B: Rev, 2016, 22(4):284-297 |
| [10] | Schmidt-Bleek K, Willie BM, Schwabe P, et al.BMPs in bone regeneration: Less is more effective,a paradigm-shift[J].Cytokine Growth Factor Rev, 2016, 27:141-148 |
| [11] | Boden SD, Kang J, Sandhu H, et al.Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective,randomized clinical pilot trial: 2002 Volvo Award in clinical studies[J].Spine, 2002, 27(23):2662-2673 |
| [12] | Boden SD, Martin GJ Jr, Horton WC, et al.Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage[J].J Spinal Disord, 1998, 11(2):95-101 |
| [13] | Boden SD, Martin GJ, Morone MA, et al.Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate[J].Spine, 1999, 24(12):1179-1185 |
| [14] | Govender S, Csimma C, Genant HK, et al.Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures[J].J Bone Joint Surg Am, 2002, 84(12):2123-2134 |
| [15] | Fiorellini JP, Howell TH, Cochran D, et al.Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation[J].J Periodontol, 2005, 76(4):605-613 |
| [16] | Boyne PJ, Lilly LC, Marx RE, et al.De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation[J].J Oral Maxillofac Surg, 2005, 63(12):1693-1707 |
| [17] | Carragee EJ, Hurwitz EL, Weiner BK.A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned[J].Spine J, 2011, 11(6):471-491 |
| [18] | Itoh K, Udagawa N, Katagiri T, et al.Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand[J].Endocrinology, 2001, 142(8):3656-3662 |
| [19] | Granholm S, Henning P, Lindholm C, et al.Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2[J].Bone, 2013, 52(1):83-92 |
| [20] | Tachi K, Takami M, Zhao BH, et al.Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts[J].Cell Tissue Res, 2010, 342(2):213-220 |
| [21] | Huntley R, Jensen E, Gopalakrishnan R, et al.Bone morphogenetic proteins: Their role in regulating osteoclast differentiation[J].Bone Rep, 2019, 10:100207- |
| [22] | Zara JN, Siu RK, Zhang XL, et al.High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo[J].Tissue Eng Part A, 2011, 17(910):1389-1399 |
| [23] | Lee KB, Taghavi CE, Song KJ, et al.Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model[J].Spine, 2011, 36(3):E149-E154 |
| [24] | Nguyen V, Meyers CA, Yan N, et al.BMP-2-induced bone formation and neural inflammation[J].J Orthop, 2017, 14(2):252-256 |
| [25] | Haidar ZS, Hamdy RC, Tabrizian M.Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering[J].Biotechnol Lett, 2009, 31(12):1825-1835 |
| [26] | Lo KWH, Ulery BD, Ashe KM, et al.Studies of bone morphogenetic protein-based surgical repair[J].Adv Drug Deliv Rev, 2012, 64(12):1277-1291 |
| [27] | Haidar ZS, Hamdy RC, Tabrizian M.Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering[J].Biotechnol Lett, 2009, 31(12):1825-1835 |
| [28] | Welch RD, Jones AL, Bucholz RW, et al.Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model[J].J Bone Miner Res, 1998, 13(9):1483-1490 |
| [29] | Bouxsein ML, Turek TJ, Blake CA, et al.Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model[J].J Bone Joint Surg Am, 2001, 83(8):1219-1230 |
| [30] | Boyne PJ.Animal studies of application of rhBMP-2 in maxillofacial reconstruction[J].Bone, 1996, 19(1 Suppl):83S-92S |
| [31] | Lee KW, Lee JS, Jang JW, et al.Tendon-bone interface healing using an injectable rhBMP-2-containing collagen gel in a rabbit extra-articular bone tunnel model[J].J Tissue Eng Regen Med, 2017, 11(5):1435-1441 |
| [32] | Geiger M.Collagen sponges for bone regeneration with rhBMP-2[J].Adv Drug Deliv Rev, 2003, 55(12):1613-1629 |
| [33] | Li RH, Wozney JM.Delivering on the promise of bone morphogenetic proteins[J].Trends Biotechnol, 2001, 19(7):255-265 |
| [34] | Ijiri S, Yamamuro T, Nakamura T, et al.Effect of sterilization on bone morphogenetic protein[J].J Orthop Res, 1994, 12(5):628-636 |
| [35] | Pekkarinen T, Hietalal O, J?ms? T, et al.Gamma irradiation and ethylene oxide in the sterilization of native reindeer bone morphogenetic protein extract[J].Scand J Surg, 2005, 94(1):67-70 |
| [36] | Pekkarinen T, Hietala O, Lindholm TS, et al.Influence of ethylene oxide sterilization on the activity of native reindeer bone morphogenetic protein[J].Int Orthop, 2004, 28(2):97-101 |
| [37] | Yamamoto M, Takahashi Y, Tabata Y.Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel[J].Tissue Eng, 2006, 12(5):1305-1311 |
| [38] | Patel ZS, Yamamoto M, Ueda H, et al.Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2[J].Acta Biomater, 2008, 4(5):1126-1138 |
| [39] | Wang HN, Boerman OC, Sariibrahimoglu K, et al.Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: Bone morphogenetic protein-2 and alkaline phosphatase[J].Biomaterials, 2012, 33(33):8695-8703 |
| [40] | Zhang WJ, Zhu C, Ye DX, et al.Porous silk scaffolds for delivery of growth factors and stem cells to enhance bone regeneration[J].PLoS One, 2014, 9(7):e102371- |
| [41] | Zhang WJ, Wang XL, Wang SY, et al.The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor[J].Biomaterials, 2011, 32(35):9415-9424 |
| [42] | Hunt DR, Jovanovic SA, Wikesj? UM, et al.Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study[J].J Periodontol, 2001, 72(5):651-658 |
| [43] | Kim J, Kim IS, Cho TH, et al.Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells[J].Biomaterials, 2007, 28(10):1830-1837 |
| [44] | Fu TS, Chen WJ, Chen LH, et al.Enhancement of posterolateral lumbar spine fusion using low-dose rhBMP-2 and cultured marrow stromal cells[J].J Orthop Res, 2009, 27(3):380-384 |
| [45] | Abarrategi A, Civantos A, Ramos V, et al.Chitosan film as rhBMP2 carrier: Delivery properties for bone tissue application[J].Biomacromolecules, 2008, 9(2):711-718 |
| [46] | Schliephake H, Weich HA, Dullin C, et al.Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid: An experimental study in rats[J].Biomaterials, 2008, 29(1):103-110 |
| [47] | Facca S, Ferrand A, Mendoza-Palomares C, et al.Bone formation induced by growth factors embedded into the nanostructured particles[J].J Biomed Nanotechnol, 2011, 7(3):482-485 |
| [48] | Hernández A, Reyes R, Sánchez E, et al.In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system[J].J Biomed Mater Res A, 2012, 100(9):2382-2391 |
| [49] | Cao LY, Kong XJ, Lin SX, et al.Synergistic effects of dual growth factor delivery from composite hydrogels incorporating 2-N,6-O-sulphated chitosan on bone regeneration[J].Artif Cells Nanomed Biotechnol, 2018, 46(sup3):S1-S17 |
| [50] | Chang PC, Liu BY, Liu CM, et al.Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds[J].J Biomed Mater Res A, 2007, 81(4):771-780 |
| [51] | Barati D, Shariati SRP, Moeinzadeh S, et al.Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel[J].J Control Release, 2016, 223:126-136 |
| [52] | Miszuk JM, Xu T, Yao Q, et al.Functionalization of PCL-3D electrospun nanofibrous scaffolds for improved BMP2-induced bone formation[J].Appl Mater Today, 2018, 10:194-202 |
| [53] | Agrawal V, Sinha M.A review on carrier systems for bone morphogenetic protein-2[J].J Biomed Mater Res, 2017, 105(4):904-925 |
| [54] | Lee EU, Lim HC, Hong JY, et al.Bone regenerative efficacy of biphasic calcium phosphate collagen composite as a carrier of rhBMP-2[J].Clin Oral Impl Res, 2016, 27(11):e91-e99 |
| [55] | Zhao J, Shen G, Liu CS, et al.Enhanced healing of rat calvarial defects with sulfated chitosan-coated calcium-deficient hydroxyapatite/bone morphogenetic protein 2 scaffolds[J].Tissue Eng Part A, 2012, 18(1/2):185-197 |
| [56] | Zhu SS, Song DH, Jiang XW, et al.Combined effects of recombinant human BMP-2 and Nell-1 on bone regeneration in rapid distraction osteogenesis of rabbit Tibia[J].Injury, 2011, 42(12):1467-1473 |
| [57] | Shah NJ, Hyder MN, Quadir MA, et al.Adaptive growth factor delivery from a polyelectrolyte coating promotes synergistic bone tissue repair and reconstruction[J].Proc Natl Acad Sci U S A, 2014, 111(35):12847-12852 |
| [58] | Jo JY, Jeong SI, Shin YM, et al.Sequential delivery of BMP-2 and BMP-7 for bone regeneration using a heparinized collagen membrane[J].Int J Oral Maxillofac Surg, 2015, 44(7):921-928 |
| [59] | Kim S, Lee S, Kim K.Bone Tissue Engineering Strategies in Co-Delivery of Bone Morphogenetic Protein-2 and Biochemical Signaling Factors[J].Adv Exp Med Biol, 2018, 1078:233-244 |
| [60] | Park SY, Kim KH, Kim S, et al.BMP-2 gene delivery-based bone regeneration in dentistry[J].Pharmaceutics, 2019, 11(8):393- |
| [61] | Jiang XQ, Zhao J, Wang SY, et al.Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs[J].Biomaterials, 2009, 30(27):4522-4532 |
| [62] | Xia LG, Xu YJ, Chang Q, et al.Maxillary sinus floor elevation using BMP-2 and nell-1 gene-modified bone marrow stromal cells and TCP in rabbits[J].Calcif Tissue Int, 2011, 89(1):53-64 |
| [63] | Zhu Y, Li DW, Zhang K, et al.Novel synthesized nanofibrous scaffold efficiently delivered hBMP-2 encoded in adenoviral vector to promote bone regeneration[J].J Biomed Nanotechnol, 2017, 13(4):437-446 |
| [64] | Kawai M, Kataoka YH, Sonobe J, et al.Non-surgical model for alveolar bone regeneration by bone morphogenetic protein-2/7 gene therapy[J].J Periodontol, 2018, 89(1):85-92 |
| [65] | Kim HJ, Chung JH, Shin SY, et al.Efficacy of rhBMP-2/Hydroxyapatite on Sinus Floor Augmentation: A Multicenter, Randomized Controlled Clinical Trial[J].J Dent Res, 2015, 94(9 Suppl):158S-165S |
| [66] | Kim MS, Lee JS, Shin HK, et al.Prospective randomized, controlled trial of sinus grafting using Escherichia-coli-produced rhBMP-2 with a biphasic calcium phosphate carrier compared to deproteinized bovine bone[J].Clin Oral Impl Res, 2015, 26(12):1361-1368 |
| [67] | Kao DW, Kubota A, Nevins M, et al.The negative effect of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus augmentation[J].Int J Periodontics Restorative Dent, 2012, 32(1):61-67 |
| [68] | Coomes AM, Mealey BL, Huynh-Ba G, et al.Buccal bone formation after flapless extraction: a randomized, controlled clinical trial comparing recombinant human bone morphogenetic protein 2/absorbable collagen carrier and collagen sponge alone[J].J Periodontol, 2014, 85(4):525-535 |
| [69] | de Freitas RM, Susin C, Spin-Neto R, et al.Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial[J].J Clin Periodontol, 2013, 40(10):968-975 |
| [70] | Nam JW, Khureltogtokh S, Choi HM, et al.Randomised controlled clinical trial of augmentation of the alveolar ridge using recombinant human bone morphogenetic protein 2 with hydroxyapatite and bovine-derived xenografts: Comparison of changes in volume[J].Br J Oral Maxillofac Surg, 2017, 55(8):822-829 |
| [71] | Dickinson BP, Ashley RK, Wasson KL, et al.Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects[J].Plast Reconstr Surg, 2008, 121(1):209-217 |
| [72] | Alonso N, Tanikawa DY, Freitas Rda S, et al.Evaluation of maxillary alveolar reconstruction using a resorbable collagen sponge with recombinant human bone morphogenetic protein-2 in cleft lip and palate patients[J].Tissue Eng Part C Methods, 2010, 16(5):1183-1189 |
| [73] | Canan LW Jr, da Silva Freitas R, Alonso N, et al.Human bone morphogenetic protein-2 use for maxillary reconstruction in cleft lip and palate patients[J].J Craniofacial Surg, 2012, 23(6):1627-1633 |
| [74] | Kim MS, Kim KJ, Kim BJ, et al.Immediate reconstruction of mandibular defect after treatment of medication-related osteonecrosis of the jaw (MRONJ) with rhBMP-2/ACS and miniplate: Review of 3 cases[J].Int J Surg Case Rep, 2020, 66:25-29 |
| [75] | Oliveira MR, Gorla LF, Gabrielli MA, et al.Off-label use of bone morphogenetic protein 2 in the reconstructions of mandibular continuity defects[J].J Craniofacial Surg, 2017, 28(1):227-230 |
| [76] | Cicciù M, Herford AS, Cicciù D, et al.Recombinant human bone morphogenetic protein-2 promote and stabilize hard and soft tissue healing for large mandibular new bone reconstruction defects[J].J Craniofacial Surg, 2014, 25(3):860-862 |
| [77] | Balaji SM.Protein-signaled guided total jaw regeneration in infantile total mandibular resection[J].Ann Maxillofac Surg, 2014, 4(2):198- |
| No related articles found! |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
